BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35639885)

  • 21. Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).
    Butcher NJ; Monsour A; Mew EJ; Szatmari P; Pierro A; Kelly LE; Farid-Kapadia M; Chee-A-Tow A; Saeed L; Monga S; Ungar W; Terwee CB; Vohra S; Fergusson D; Askie LM; Williamson PR; Chan AW; Moher D; Offringa M
    Trials; 2019 Mar; 20(1):161. PubMed ID: 30841935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trial registration as a safeguard against outcome reporting bias and spin? A case study of randomized controlled trials of acupuncture.
    Won J; Kim S; Bae I; Lee H
    PLoS One; 2019; 14(10):e0223305. PubMed ID: 31581278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Consensus Statement for Protocols of Factorial Randomized Trials: Extension of the SPIRIT 2013 Statement.
    Kahan BC; Hall SS; Beller EM; Birchenall M; Elbourne D; Juszczak E; Little P; Fletcher J; Golub RM; Goulao B; Hopewell S; Islam N; Zwarenstein M; Chan AW; Montgomery AA
    JAMA Netw Open; 2023 Dec; 6(12):e2346121. PubMed ID: 38051535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Evaluation of Reporting Guidelines and Clinical Trial Registry Requirements Among Addiction Medicine Journals.
    Cooper CM; Gray H; Barcenas L; Torgerson T; Checketts JX; Vassar M
    J Am Osteopath Assoc; 2020 Dec; 120(12):823-830. PubMed ID: 33075122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study.
    Zou CX; Becker JE; Phillips AT; Garritano JM; Krumholz HM; Miller JE; Ross JS
    Trials; 2018 Oct; 19(1):581. PubMed ID: 30352601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.
    Chan AW; Tetzlaff JM; Gøtzsche PC; Altman DG; Mann H; Berlin JA; Dickersin K; Hróbjartsson A; Schulz KF; Parulekar WR; Krleza-Jeric K; Laupacis A; Moher D
    BMJ; 2013 Jan; 346():e7586. PubMed ID: 23303884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compliance with requirements for registration and reporting of results in trials of mesenchymal stromal cells for musculoskeletal disorders: a systematic review.
    Holtedahl R; Brox JI
    BMJ Open; 2024 Jun; 14(6):e081343. PubMed ID: 38925685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do emergency medicine journals promote trial registration and adherence to reporting guidelines? A survey of "Instructions for Authors".
    Sims MT; Henning NM; Wayant CC; Vassar M
    Scand J Trauma Resusc Emerg Med; 2016 Nov; 24(1):137. PubMed ID: 27881175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic evaluation of the patient-reported outcome (PRO) content of clinical trial protocols.
    Kyte D; Duffy H; Fletcher B; Gheorghe A; Mercieca-Bebber R; King M; Draper H; Ives J; Brundage M; Blazeby J; Calvert M
    PLoS One; 2014; 9(10):e110229. PubMed ID: 25333349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving the patient-reported outcome sections of clinical trial protocols: a mixed methods evaluation of educational workshops.
    King MT; Tait MA; Campbell R; Müller F; Rutherford C; Beckmore C; Chima S; Langbecker D; Shaw J; Mercieca-Bebber R
    Qual Life Res; 2022 Oct; 31(10):2901-2916. PubMed ID: 35553325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension.
    Cruz Rivera S; Liu X; Chan AW; Denniston AK; Calvert MJ;
    Lancet Digit Health; 2020 Oct; 2(10):e549-e560. PubMed ID: 33328049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.
    Turner L; Shamseer L; Altman DG; Weeks L; Peters J; Kober T; Dias S; Schulz KF; Plint AC; Moher D
    Cochrane Database Syst Rev; 2012 Nov; 11(11):MR000030. PubMed ID: 23152285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How to use the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) in orthodontic research.
    Novaes IC; Clementino LC; Flores-Mir C; Marques LS; Martins-Júnior PA
    Dental Press J Orthod; 2022; 27(3):e2220290. PubMed ID: 35792787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The reporting quality of N-of-1 trials and protocols still needs improvement.
    Wei Z; Chu X; Han J; Zhang N; Li Y; Yang C; Wang Q; Li J; Belal AA; Yan P; Li X; Yang K
    J Evid Based Med; 2022 Dec; 15(4):365-372. PubMed ID: 35919928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of protocols and registry entries to published reports for randomised controlled trials.
    Dwan K; Altman DG; Cresswell L; Blundell M; Gamble CL; Williamson PR
    Cochrane Database Syst Rev; 2011 Jan; 2011(1):MR000031. PubMed ID: 21249714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of trial registration with the results and conclusions of published trials of new oncology drugs.
    Rasmussen N; Lee K; Bero L
    Trials; 2009 Dec; 10():116. PubMed ID: 20015404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reporting characteristics and quality of randomized controlled trial protocols in traditional Chinese medicine: a cross-sectional study.
    Zhang L; Li H; Hu L; Ou X; Tan H; Zhang X; Lau CT; Lyu A; Bian Z; Zhang X
    Front Pharmacol; 2024; 15():1389808. PubMed ID: 38910893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of clinical trial protocols for pathology content using the SPIRIT-Path guidelines highlights areas for improvement.
    Robinson P; Bacon CM; Lim SJ; Shaaban AM; Brierley D; Lewis I; Harrison DJ; Kendall TJ; Robinson M
    J Pathol Clin Res; 2022 Sep; 8(5):411-421. PubMed ID: 35638866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics and publication fate of unregistered and retrospectively registered clinical trials submitted to
    Loder E; Loder S; Cook S
    BMJ Open; 2018 Feb; 8(2):e020037. PubMed ID: 29453302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.